Appco Pharma Venlafaxine 150mg Tablets Recall: Missing Tab ID Risk

Take action

Contact the company & request your remedy

Recalling firmAppco Pharma LLC262 Old New Brunswick Rd Unit N · Piscataway, NJ 08854-3756

No email on file — write to the address above instead.

✎ GovInfoNow plain-language explainer

What happened, in plain English

Appco Pharma is recalling 150mg Venlafaxine Extended-Release Tablets because they lack a tab ID on one side. This could lead to misidentification or safety issues for patients taking the medication.

Why it’s dangerous

The missing tab ID on the tablet can make it difficult to identify the product correctly. This could lead to misidentification or safety concerns if the tablets are not properly distinguished from other medications.

Who’s affected

Prescription patients using the recalled Venlafaxine Extended-Release Tablets. Those with the specific lot number (2402101UR) are most at risk.

How to tell if you have this one

Check for the lot number 2402101UR on the packaging. The product is a prescription-only 150mg Venlafaxine Extended-Release Tablets with NDC 43598-943-90.

Brand
Appco Pharma
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Product Packaging
Look for the lot number 2402101UR on the packaging to confirm if the product is recalled.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall does not state that the product is unsafe; it indicates a missing tab ID that could affect identification.

What should I do if I have this product?

The recall does not specify a remedy, so no action is required beyond checking the lot number.

How can I confirm if I have the recalled product?

Check the lot number 2402101UR on the packaging. The product is a prescription-only 150mg Venlafaxine Extended-Release Tablets with NDC 43598-943-90.

Take action

Contact Appco Pharma

We’ve drafted a message you can send Appco Pharma to request your refund or repair — edit it as you like.

✉️ Open in email

Subject: Recall D-0208-2025 — Appco Pharma Appco Pharma

Hello,

I own a Appco Pharma that is covered by recall D-0208-2025 from Appco Pharma.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0208-2025 (January 16, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0208-2025 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.

Appco Pharma LLC recalls Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.

Recall notice